Latest KFF Health News Content

Latest KFF Health News Stories

California Aims To Limit Surprise Medical Bills

KFF Health News Original

The problem, known as balance billing, happens when patients are treated by an out-of-network professional at an in-network facility. Gov. Jerry Brown is expected to sign the legislation.

Iowa Supreme Court Asked To Review Governor’s Veto That Closed Two Mental Health Institutions

Morning Briefing

Meanwhile, Boston-area health centers get funding to improve children’s access to mental health services. In Ohio, drug treatment rules are debated. And Washington state’s largest psychiatric hospital is faulted for mistakes and lax security in a new report, following the escape of two violent patients.

Prostate Cancer Study Offers Insights Regarding Value Of Treatments

Morning Briefing

Researchers hailed findings that indicate the survival rate for early-stage prostate cancer is 99 percent after 10 years, regardless of whether men opted for surgery, radiation or were actively monitoring their conditions.

The Uphill Battle Of Fighting Zika: Americans Just Aren’t Worried Enough

Morning Briefing

A recent survey showed that two-thirds of Americans were “not too” worried or “not at all” worried about the disease. And without proper funding, public education becomes a crucial element to battling Zika. If people don’t care, though, that leaves officials at a loss. Meanwhile, a new poll shows that there are shifting views on late-term abortions now that the virus is spreading.

Capitalizing On Renewed Interest From Clinton, Senators Launch Public Option Effort

Morning Briefing

The resolution to focus on building out a public option — introduced by Sens. Jeff Merkley, Chuck Schumer, Patty Murray, Dick Durbin and Bernie Sanders — follows several tumultuous months for the exchanges.

Those Drugmaker Coupons Cut Costs In The Short-Term, But Are Actually Driving Up Prices

Morning Briefing

The Associated Press breaks down the pros and cons of the coupons, which are facing increased scrutiny because of the EpiPen controversy. Meanwhile, Allergan strengthens its skin-care pipeline by acquiring Vitae.

EpiPen-Maker’s CEO To Face Congressional Fire At Hearing On Price Gouging

Morning Briefing

Chief Executive Heather Bresch will testify in front of the House Oversight and Government Reform Committee next week. Meanwhile, senators plan to introduce a bill requiring drugmakers to give a 30-day notice and justification of any prescription drug price increase of more than 10 percent.